-
2
-
-
0019155523
-
Differential effects of amphetamine and neuroleptics on negative vs. Positive symptoms in schizophrenia
-
Angrist B, Rotrosen J, Gershon S (1980) Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology 72:17-19
-
(1980)
Psychopharmacology
, vol.72
, pp. 17-19
-
-
Angrist, B.1
Rotrosen, J.2
Gershon, S.3
-
3
-
-
0019155756
-
What is the best maintenance dose of neuroleptics in schizophrenia?
-
Baldessarini RJ, Davis JM (1980) What is the best maintenance dose of neuroleptics in schizophrenia? Psychiatry Res 3:115-122
-
(1980)
Psychiatry Res
, vol.3
, pp. 115-122
-
-
Baldessarini, R.J.1
Davis, J.M.2
-
4
-
-
0030065502
-
Olanzapine versus placebo and haloperidol. Acute phase results of the North American double-blind olanzapine trial
-
Beasley CM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S and the olanzapine HGAD Study Group (1996) Olanzapine versus placebo and haloperidol. Acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 14:97-104
-
(1996)
Neuropsychopharmacology
, vol.14
, pp. 97-104
-
-
Beasley, C.M.1
Tollefson, G.2
Tran, P.3
Satterlee, W.4
Sanger, T.5
Hamilton, S.6
-
5
-
-
0028789388
-
Risperidone in the treatment of negative symptoms of schizophrenia:A meta-analysis
-
Carman J, Peuskens J, Vangeneugden A (1995) Risperidone in the treatment of negative symptoms of schizophrenia:a meta-analysis. Int Clin Psychopharmacol 10:207-213
-
(1995)
Int Clin Psychopharmacol
, vol.10
, pp. 207-213
-
-
Carman, J.1
Peuskens, J.2
Vangeneugden, A.3
-
6
-
-
0002983898
-
Domains of psychopathology relevant to the study of etiology and treatment of schizophrenia
-
Schultz SC, Tamminga CT (eds), Oxford Press, New York
-
Carpenter WT, Buchanon RW (1989) Domains of psychopathology relevant to the study of etiology and treatment of schizophrenia. In: Schultz SC, Tamminga CT (eds) Schizophrenia: scientific progress. Oxford Press, New York
-
(1989)
Schizophrenia: Scientific Progress
-
-
Carpenter, W.T.1
Buchanon, R.W.2
-
7
-
-
0025975251
-
Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia
-
Casey DE (1991) Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Schizophrenia Res 4:109-120
-
(1991)
Schizophrenia Res
, vol.4
, pp. 109-120
-
-
Casey, D.E.1
-
8
-
-
10544243792
-
Side effect profiles of new antipsychotic agents
-
Casey DE (1996) Side effect profiles of new antipsychotic agents. J Clin Psychiatry 57:40-45
-
(1996)
J Clin Psychiatry
, vol.57
, pp. 40-45
-
-
Casey, D.E.1
-
9
-
-
0001929571
-
Drugs in the treatment of psychosis: Controlled studies
-
Solomon P (ed), Grune and Stratton, New York
-
Cole JO, Goldberg C, Davis JM (1966) Drugs in the treatment of psychosis: controlled studies. In: Solomon P (ed) Psychiatric drugs. Grune and Stratton, New York, pp 153-180
-
(1966)
Psychiatric Drugs
, pp. 153-180
-
-
Cole, J.O.1
Goldberg, C.2
Davis, J.M.3
-
10
-
-
0001584620
-
A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia
-
Cooper SJ, Tweed J, Raniwalla J, Butler A (2000) A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. Acta Psychiatr Scand 101:218-225
-
(2000)
Acta Psychiatr Scand
, vol.101
, pp. 218-225
-
-
Cooper, S.J.1
Tweed, J.2
Raniwalla, J.3
Butler, A.4
-
11
-
-
0016765907
-
Overview: Maintenance therapy in psychiatry, I: Schizophrenia
-
Davis JM (1975) Overview: maintenance therapy in psychiatry, I: schizophrenia. Am J Psychiatry 132:1237-1245
-
(1975)
Am J Psychiatry
, vol.132
, pp. 1237-1245
-
-
Davis, J.M.1
-
13
-
-
0024405884
-
The positive-negative distinction in drug-free schizophrenic patients: Stability, response to neuroleptics, and prognostic significance
-
Kay SR, Singh MM (1989) The positive-negative distinction in drug-free schizophrenic patients: stability, response to neuroleptics, and prognostic significance. Arch Gen Psychiatry 46:711-718
-
(1989)
Arch Gen Psychiatry
, vol.46
, pp. 711-718
-
-
Kay, S.R.1
Singh, M.M.2
-
14
-
-
0026534839
-
A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia
-
King DJ, Blomquist M, Cooper SJ, Doherty MM, Mitchell MJ, Montgomery RC (1992) A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia. Psychopharmacology 107:175-179
-
(1992)
Psychopharmacology
, vol.107
, pp. 175-179
-
-
King, D.J.1
Blomquist, M.2
Cooper, S.J.3
Doherty, M.M.4
Mitchell, M.J.5
Montgomery, R.C.6
-
15
-
-
0027318059
-
Interaction of antipsychotic drugs with neuro-transmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: Role of 5HT2 receptors
-
Leysen JE, Janssen PMF, Schotte A, Luyten WHML, Megens AAHP (1993) Interaction of antipsychotic drugs with neuro-transmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors. Psychopharmacology 112:S40-S54
-
(1993)
Psychopharmacology
, vol.112
-
-
Leysen, J.E.1
Janssen, P.M.F.2
Schotte, A.3
Luyten, W.H.M.L.4
Megens, A.A.H.P.5
-
17
-
-
0029886798
-
Zotepine: Preclinical tests predict antipsychotic efficacy and an atypical profile
-
Needham PL, Atkinson J, Skill MJ, Heal DJ (1996) Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profile. Psychopharmacol Bull 32:123-128
-
(1996)
Psychopharmacol Bull
, vol.32
, pp. 123-128
-
-
Needham, P.L.1
Atkinson, J.2
Skill, M.J.3
Heal, D.J.4
-
18
-
-
0029889665
-
A comparison of an atypical antipsychotic, zotepine, versus haloperidol in patients with acute exacerbation of schizophrenia
-
Petit M, Raniwalla J, Tweed J, Leutenegger E, Dollfus S, Kelly F (1996) A comparison of an atypical antipsychotic, zotepine, versus haloperidol in patients with acute exacerbation of schizophrenia. Psychopharmacol Bull 32:81-88
-
(1996)
Psychopharmacol Bull
, vol.32
, pp. 81-88
-
-
Petit, M.1
Raniwalla, J.2
Tweed, J.3
Leutenegger, E.4
Dollfus, S.5
Kelly, F.6
-
19
-
-
0028261434
-
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
-
Roth BL, Craigo SC, Choudhar MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268:1403-1409
-
(1994)
J Pharmacol Exp Ther
, vol.268
, pp. 1403-1409
-
-
Roth, B.L.1
Craigo, S.C.2
Choudhar, M.S.3
Uluer, A.4
Monsma F.J., Jr.5
Shen, Y.6
Meltzer, H.Y.7
Sibley, D.R.8
-
21
-
-
0031836975
-
Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses
-
Tran PV, Dellva HA, Tollefson GD, Wentley AL, Beasley CM Jr (1998) Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses. Br J Psychiatry 172:499-505
-
(1998)
Br J Psychiatry
, vol.172
, pp. 499-505
-
-
Tran, P.V.1
Dellva, H.A.2
Tollefson, G.D.3
Wentley, A.L.4
Beasley C.M., Jr.5
-
22
-
-
0023232864
-
Behavioural toxicity of antipsychotic drugs
-
Van Putten T, Marder SR (1987) Behavioural toxicity of antipsychotic drugs. J Clin Psychiatry 48[suppl]:13-19
-
(1987)
J Clin Psychiatry
, vol.48
, Issue.SUPPL.
, pp. 13-19
-
-
Van Putten, T.1
Marder, S.R.2
-
23
-
-
0031013410
-
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment
-
Viguera AC, Baldesarini RJ, Hegarty JD, Van Kammen DP, Tohen M (1997) Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry 54:49-55
-
(1997)
Arch Gen Psychiatry
, vol.54
, pp. 49-55
-
-
Viguera, A.C.1
Baldesarini, R.J.2
Hegarty, J.D.3
Van Kammen, D.P.4
Tohen, M.5
-
24
-
-
0029985119
-
Atypical antipsychotic drugs and long-term outcome in schizophrenia
-
Weiden P, Aquila R, Standard J (1996) Atypical antipsychotic drugs and long-term outcome in schizophrenia. J Clin Psychiatry 57[Suppl 11]:53-60
-
(1996)
J Clin Psychiatry
, vol.57
, Issue.SUPPL. 11
, pp. 53-60
-
-
Weiden, P.1
Aquila, R.2
Standard, J.3
|